Covidien launches first U.S. product from its Confluent Surgical acquisition

November 12, 2009 by MassDevice staff

Three years after purchasing Confluent Surgical for $245 million, the medical device colossus launches the DuraSeal Spine Sealant in the U.S.

Covidien launches first product from its Confluent Surgical acquisition

It took seven years and a $245 million merger, but the DuraSeal Spine Sealant finally hit the market in the U.S.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp